Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
RUBRA MEDICAMENTS LTD. - Revised Outcome Of Board Meeting
Download announcement < Back
14 Nov 2022
1. This is to inform you that, the Board of Directors of the Company at its meeting held on Thursday, November 10, 2022 inter alia, has considered and approved the following:&lt;BR&gt; &lt;BR&gt; A. Standalone Unaudited Financial Results along with limited review report, Asset and liability statement and Cash Flow Statement of the Company for the half year ended September 30, 2022. &lt;BR&gt; &lt;BR&gt; B. Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015 for the half year ended September 30, 2022&lt;BR&gt; &lt;BR&gt; The time of commencement of the Board Meeting was 03.00 PM and the time of conclusion was 3.30 PM &lt;BR&gt;
View all announcements for RUBRA MEDICAMENTS LTD. Source: BSE India